J&J Janssen arm to Buy Benevir Biopharm

10.05.2018 - BeneVir Biopharm, a privately-held biotechnology company in the life science portfolio of the HC2 holding, will be bought by Janssen Biotech, a subsidiary of Johnson & Johnson...